Regeneron (NASDAQ: REGN) reported Q4 EPS of $12.56, $2.39 better than the analyst estimate of $10.17. Revenue for the quarter came in at $3.41 million versus the consensus estimate of $3.13 billion.

For earnings history and earnings-related data on Regeneron (REGN) click here.